[Pathogenesis and therapy of vascular cephalalgia].
D002110:Caffeine / Q000627:therapeutic use*; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D006261:Headache; D008881:Migraine Disorders
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D002110:Caffeine
CAFFEINE/therapeutic use; ERGOT ALKALOIDS/therapeutic use; MIGRAINE
Beitrag zur Genese und Therapie vaskulärer Zephalgien.